R. Hobson

发表

Treatment and outcome of Wilms' tumour patients: an analysis of all cases registered in the UKW3 trial.

A. Kelsey, K. Pritchard-Jones, B. Messahel, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of temozolomide in relapsed or refractory high-risk neuroblastoma: a joint Société Française des Cancers de l'Enfant and United Kingdom Children Cancer Study Group-New Agents Group Study.

K. McHugh, H. Brisse, G. Vassal, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

A. Attarbaschi, K. Horibe, A. Uyttebroeck, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anaplastic large cell lymphoma in childhood: analysis of 72 patients treated on The United Kingdom Children's Cancer Study Group chemotherapy regimens

C. R. Pinkerton, K. McCarthy, R. Hobson, 2002, British journal of haematology.

Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial.

C. Brightling, C. Brookes, M. Steiner, 2022, The Lancet. Respiratory medicine.

Outcome of relapsed or refractory childhood B‐cell acute lymphoblastic leukaemia and B‐cell non‐Hodgkin's lymphoma treated with the UKCCSG 9003/9002 protocols

C. R. Pinkerton, R. Hobson, M. Gerrard, 2001, British journal of haematology.

Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (B-NHL)--results of the UKCCSG 9003 protocol.

R. Hobson, C. Pinkerton, M. Gerrard, 1998, British Journal of Cancer.

Prospective validation of renal function-based carboplatin dosing in children with cancer: A United Kingdom Children's Cancer Study Group Trial.

A. Boddy, M. Stevens, I. Lewis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prospective V alidation o f R enal F unction-Based Carboplatin D osing i n C hildren W ith C ancer: A U nited Kingdom C hildren's C ancer S tudy G roup T rial

A. Boddy, M. Stevens, I. Lewis, 2000 .

Immunodeficiency‐related lymphoproliferative disorders: prospective data from the United Kingdom Children's Cancer Study Group Registry

D. Vergani, C. R. Pinkerton, D. Kelly, 2002, British journal of haematology.

Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study.

P D Griffiths, D Frappaz, P. Griffiths, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Endometrial safety, overall safety and tolerability of transdermal continuous combined hormone replacement therapy over 96 weeks: a randomized open-label study

H. Concin, J. Heikkinen, C. De Geyter, 2006, Climacteric : the journal of the International Menopause Society.

Allele loss at 16q defines poorer prognosis Wilms tumour irrespective of treatment approach in the UKW1-3 clinical trials: a Children's Cancer and Leukaemia Group (CCLG) Study.

N. Sebire, Chris Jones, R. A’Hern, 2009, European journal of cancer.

Surgical complications after immediate nephrectomy versus preoperative chemotherapy in non-metastatic Wilms' tumour: findings from the 1991-2001 United Kingdom Children's Cancer Study Group UKW3 Trial.

K. Pritchard-Jones, B. Messahel, M. Powis, 2013, Journal of pediatric surgery.

A phase I study of nolatrexed dihydrochloride in children with advanced cancer. A United Kingdom Children's Cancer Study Group Investigation

A. Boddy, I. Lewis, B. Morland, 2001, British Journal of Cancer.

Temozolomide i n M alignant G liomas o f C hildhood: A U nited Kingdom C hildren's C ancer S tudy G roup a nd F rench S ociety for P ediatric O ncology I ntergroup S tudy

D. Frappaz, A. Jouvet, G. Vassal, 2002 .

Acute neurotoxicity in children with advanced stage B-non-Hodgkin's lymphoma and B-acute lymphoblastic leukaemia treated with the United Kingdom children cancer study group 9002/9003 protocols.

C. R. Pinkerton, E. Bouffet, R. Hobson, 2004, European journal of cancer.

Long-term outcome for immune suppression and immune related lymphoproliferative disorder: prospective data from the United Kingdom Children's Leukaemia and Cancer Group registry 1994–2004

C. R. Pinkerton, A. Wotherspoon, N. Hadžić, 2012, Leukemia & lymphoma.

OA07.08 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed, Phase II Platform Study in Patients with NSCLC, who Progressed on Anti-PD(L)1 Therapy

S. Barry, Michael Thomas, N. Rizvi, 2021 .

OA15.05 HUDSON: An Open-Label, Multi-Drug, Biomarker-Directed Phase 2 Study in NSCLC Patients Who Progressed on Anti-PD-(L)1 Therapy

S. Barry, B. Besse, P. Forde, 2022, Journal of Thoracic Oncology.

Localized non‐Hodgkin's lymphoma with B‐cell histology: cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985–1996)

R. Hobson, M. Gerrard, J. Imeson, 2003, British journal of haematology.

Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol

O. Eden, R. Hobson, R. Carter, 2000, British Journal of Cancer.